Pharma-Bio 2Q14 Update

$9 Billion in Project Starts Reflects 91% Gain in Industry Capital Investment, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Apr 18, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When June 2014 draws to a close, the Pharmaceutical-Biotech Industry is forecast to have launched nearly $9 billion worth of North American capital and maintenance projects during the previous three months. The stunning number reflects a 91% increase over last year's figures.

Other companies featured: Emergent Biosolutions (NYSE:EBS), Endo Pharmaceuticals (NASDAQ:ENDP)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.jsp?newsitemID=241703&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact:
Joe Govreau
713-783-5147